Stephanie B. Geisler
Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer.
Journal: Future oncology (London, England)
Published: July 29, 2024
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.
Journal: Breast cancer research and treatment
Published: January 19, 2024
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development.
Journal: Genome medicine
Published: June 09, 2023
Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy.
Journal: Genome medicine
Published: November 26, 2021
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.
Journal: Breast cancer research and treatment
Published: September 23, 2020
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors.
Journal: Future oncology (London, England)
Published: September 13, 2019
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.
Journal: Molecular oncology
Published: March 06, 2015
Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.
Journal: PloS one
Published: March 16, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026